Denali Therapeutics (DNLI) Net Margin (2018 - 2026)
Denali Therapeutics' Net Margin was -3539.21% in Q2 2026.
Powered by 
Analysis
Denali Therapeutics (DNLI) Net Margin (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Denali Therapeutics' Net Margin was -14191.20% through Jun 30, 2026; for FY2023, it was -43.94%, up 256.62 percentage points from FY2022.
- Net Margin shows a five-year change of -15.88 percentage points (FY2018 to FY2023).
- In earlier years, Net Margin was -300.56% in FY2022 (+296.60 pp), -597.15% in FY2021 (-618.35 pp), 21.19% in FY2020 (+761.93 pp) and -740.74% in FY2019 (-712.68 pp).
- The Q2 2026 figure marks the highest quarterly Net Margin since Q2 2023.
- The best year-over-year quarter for Net Margin over five years was Q1 2022 (a gain of 729.26 percentage points); the worst was Q3 2023 (a drop of 4939.12 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Denali Therapeutics | 3.35 Bn | 3.35 Bn | 3.51 Mn | -3,539.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,539.21% |
| Sep 30, 2023 | -7,841.59% |
| Jun 30, 2023 | 62.35% |
| Mar 31, 2023 | -312.40% |
| Dec 31, 2022 | -959.62% |
| Sep 30, 2022 | -2,902.47% |
| Jun 30, 2022 | -112.03% |
| Mar 31, 2022 | -154.77% |
| Dec 31, 2021 | -601.41% |
| Sep 30, 2021 | -1,600.53% |
| Jun 30, 2021 | -264.58% |
| Mar 31, 2021 | -884.02% |
| Dec 31, 2020 | 77.30% |
| Sep 30, 2020 | -619.91% |
| Jun 30, 2020 | -1,004.93% |
| Mar 31, 2020 | -1,575.00% |
| Dec 31, 2019 | -1,156.36% |
| Sep 30, 2019 | -340.05% |
| Jun 30, 2019 | -1,389.97% |
| Mar 31, 2019 | -927.28% |
API Access
Denali Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();